                         SEQUENCE LISTING

<110>  Rubius Therapeutics, Inc.
 
<120>  METHODS OF GENERATING ENUCLEATED ERYTHROID CELLS

<130>  47472-0002WO1

<140>  PCT/US2020/034387
<141>  2020-05-22

<150>  US 62/852,930
<151>  2019-05-24

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EPO mimetic peptide

<400>  1

Gly Gly Thr Tyr Ser Cys His Phe Gly Pro Leu Thr Trp Val Cys Lys 
1               5                   10                  15      


Pro Gln Gly Gly 
            20  


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  EPO mimetic peptide

<400>  2

Tyr Ser Cys His Phe Gly Pro Leu Thr Trp Val Cys Lys 
1               5                   10              


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker

<400>  3

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker

<400>  4

Ala Gly Ser Thr 
1               


